Anatara Lifesciences Ltd (
Highlights for the period include:
- APVMA approval and product application of Detach
- Steven Lydeamore appointed CEO
- Product Development Advisory Board established
- Progression of GaRP dietary supplement development program
To view the full report, please visit:
http://abnnewswire.net/lnk/V5527M9X
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
Contact
General inquiriesSteven Lydeamore
CEO
Anatara Lifesciences
T: +61-438-027-172
E: slydeamore@anatara.com
Media inquiries:
Jane Lowe
Managing Director
IR Department
T: +61-411-117-774
E: jane.lowe@irdepartment.com.au
Related Companies
Related Industry Topics: